- Home
- MBRX vs LDWY Comparison
MBRX vs LDWY Comparison
Compare MBRX & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBRX
- LDWY
- Stock Information
- Founded
- MBRX 2015
- LDWY 1990
- Country
- MBRX United States
- LDWY United States
- Employees
- MBRX N/A
- LDWY N/A
- Industry
- MBRX Biotechnology: Pharmaceutical Preparations
- LDWY Advertising
- Sector
- MBRX Health Care
- LDWY Consumer Discretionary
- Exchange
- MBRX Nasdaq
- LDWY Nasdaq
- Market Cap
- MBRX 7.7M
- LDWY 6.9M
- IPO Year
- MBRX 2016
- LDWY 1991
- Fundamental
- Price
- MBRX $2.70
- LDWY $3.69
- Analyst Decision
- MBRX Strong Buy
- LDWY
- Analyst Count
- MBRX 3
- LDWY 0
- Target Price
- MBRX $31.00
- LDWY N/A
- AVG Volume (30 Days)
- MBRX 54.8K
- LDWY 5.1K
- Earning Date
- MBRX 11-08-2024
- LDWY 11-29-2024
- Dividend Yield
- MBRX N/A
- LDWY N/A
- EPS Growth
- MBRX N/A
- LDWY N/A
- EPS
- MBRX N/A
- LDWY N/A
- Revenue
- MBRX N/A
- LDWY $24,813,000.00
- Revenue This Year
- MBRX N/A
- LDWY N/A
- Revenue Next Year
- MBRX N/A
- LDWY N/A
- P/E Ratio
- MBRX N/A
- LDWY N/A
- Revenue Growth
- MBRX N/A
- LDWY N/A
- 52 Week Low
- MBRX $0.40
- LDWY $3.02
- 52 Week High
- MBRX $6.24
- LDWY $6.88
- Technical
- Relative Strength Index (RSI)
- MBRX 53.82
- LDWY 54.80
- Support Level
- MBRX $2.50
- LDWY $3.31
- Resistance Level
- MBRX $3.33
- LDWY $3.99
- Average True Range (ATR)
- MBRX 0.24
- LDWY 0.21
- MACD
- MBRX 0.04
- LDWY 0.02
- Stochastic Oscillator
- MBRX 39.42
- LDWY 44.87
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two Industry Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.